D48.11
Desmoid tumor
Clinical Classification Guidelines
Inclusion Terms
- Aggressive fibromatosis
Medical Intelligence & Overview
A desmoid tumor, also known as aggressive fibromatosis, is a rare type of benign growth characterized by the abnormal proliferation of fibrous tissue. Despite being non-cancerous, desmoid tumors can be locally aggressive, growing into surrounding tissues and structures. They often pose challenges due to their tendency to recur after treatment, making diagnosis and management important considerations.
Causes & Symptoms
Clinical Causes: Genetic factors, such as mutations in the APC gene or beta-catenin gene A history of familial adenomatous polyposis (FAP) Previous trauma or surgical injury to the affected area Hormonal influences, particularly during pregnancy or with hormonal therapy
Key Symptoms: A painless, firm, and slow-growing mass or lump Swelling or visible bulge in the affected area Pain or discomfort if the tumor presses on nerves or other structures Limited range of motion if located near joints In some cases, the tumor may be asymptomatic and discovered incidentally
Diagnostic & Treatment
Diagnosis Path: Diagnosing a desmoid tumor involves multiple steps, including physical examinations and imaging studies such as MRI or CT scans to determine the size and extent of the growth. A biopsy, where a small tissue sample is removed and examined under a microscope, is often required to confirm the diagnosis and differentiate it from other soft tissue tumors.
Treatment Protocols: Treatment options for desmoid tumors vary based on the size, location, and growth behavior of the tumor, as well as patient health. Common approaches include: - Surgical removal of the tumor, aiming to excise it completely with clear margins - Radiation therapy to manage non-resectable or recurrent tumors - Systemic treatments such as hormonal therapy, non-steroidal anti-inflammatory drugs (NSAIDs), or targeted therapies - Observation or 'watchful waiting' in cases where the tumor is not causing symptoms or growth is slow Management often requires a multidisciplinary approach to balance tumor control with preservation of function and quality of life.
Clinical Advice & FAQs
Billing Guidance
Is D48.11 a billable ICD-10 code?
Yes, D48.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D48.11?
Clinical documentation must specify the nature of Desmoid tumor and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
